|
Resources
Chromax Chromium Picolinate Clincially Effective: Backed by Clinical Research
The United States Food and Drug Administration has deemed chromium picolonate 'safe'. With more than a decade's worth of clinical research, the safety, effectiveness and quality of Chromax® is without question. Time after time, in trials conducted by leading scientists at renowned institutions and according to strict pharmaceutical industry standards, Chromax® has earned the respect of healthcare practitioners and the industry.
Consider the following informational resources for you and your patients:
Web Sites
Publications
Dietary Recommendations
-
National Research Council. Recommended Dietary Allowances . 10th edition, 1989 Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc . Washington , D.C. : National Academy Press, 2002.
- Institute of Medicine. Draft Prototype Monograph: Chromium Picolinate. Washington , DC : National Academy of Sciences, 2003.
Chromium in the Diet
- Anderson RA, Kozlovsky AS. Chromium intake, absorption and excretion of subjects consuming self-selected diets.Am J Clin Nutr. 1985; 41(6): 1177-83.
- Anderson RA, Bryden NA, Polansky MM. Dietary chromium intake. Freely chosen diets, institutional diet, and individual foods. Biol Trace Elem Res. 1992; 32:117-21.
- Davies S, Howard JM, Hunnisett A, et al. Age-related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients--implications for the prevention of cardiovascular disease and type II diabetes mellitus. Metabolism 46:469-473, 1997.
- Rimm EB, Guallar E, Giovannucci E, et al . Toenail chromium levels and risk of coronary heart disease among normal and overweight men. Presented at the American Heart Association's 42nd Annual Conference on Cardiovascular Disease, Epidemiology and Prevention, April 24, 2002 , Honolulu , Hawaii.
Metabolic Syndrome and Insulin Resistance
- Cefalu WT, Bell-Farrow AD, Stegner J, et al 1999. Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exp Med 12:71-83
- Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163(4):427-36, 2003.
- Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356-9, 2002.
- Isomaa B, Almgren P, Tuomi T, et al . Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24(4):683-9, 2001.
- Dr. Peter J. Havel, A SCIENTIFIC REVIEW:The Role of Chromium in Insulin Resistance, Nutrition21, Inc. 2004
Chromium Picolinate Safety
- Anderson RA, Bryden NA, Polansky MM. Lack of toxicity of chromium chloride and chromium picolinate in rats. J Am Coll Nutr 16:273-279, 1997.
- Berner TO, Murphy MM, Slesinski R. Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement. Food and Chemical Toxicology 42:1029-1042, 2004.
- National Toxicology Program (NTP). Chromium Picolinate. http://ntp-server.niehs.gov (Search: Chromium Picolinate). 2003.
- Institute of Medicine (IOM). Chromium Picolinate—Prototype Monograph Summary. In: Dietary Supplements--A Framework for Evaluating Safety . Washington , DC : National Academy of Sciences Press, 2004.
*These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.
|
